REGENXBIO (RGNX) Priced

Developing gene therapies for rare diseases with a proprietary delivery platform.

Health Care - Biotechnology

IPO Performance
Latest Trade $17.30 0.00 (0.0%)
First Day Return 38.4%
Return from IPO -21.4%
 
REGENXBIO IPO News more
  • .
IPO Data
IPO File Date 08/17/2015
Offer Price $22.00
Price Range $22.00 - $22.00
Offer Shares (mm) 6.3
Deal Size ($mm) 139
 
IPO Data
IPO Date 09/16/2015
Offer Price $22.00
Price Range $22.00 - $22.00
Offer Shares (mm) 6.3
Deal Size ($mm) $139
 
Underwriters
more
Business Overview
Developing gene therapies for rare diseases with a proprietary delivery platform.
Developing gene therapies for rare diseases with a proprietary delivery platform.
more
Company Data
Headquarters Rockville, MD
Founded 2008
Employees 18
Website www.regenxbio.com
 

Performance vs. IPO Index (IPOUSA)